Motility News

The AGA applauded the reintroduction of the Treat and Reduce Obesity Act into the 118th Congress as this bill would expand Medicare coverage for screening and treatment of obesity by health care providers specializing in obesity care.

A personal injury law firm has filed a lawsuit against Novo Nordisk and Eli Lilly, alleging the manufacturers “downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro,” such as gastroparesis and gastroenteritis.

A new clinical practice update from the AGA highlights the value of physical examination, effective communication and integrated care in the diagnosis and management of patients with belching, abdominal bloating or distention.

Researchers have developed and validated a five-point score to identify patients with celiac disease at risk for persistent villous atrophy, which is associated with complications and mortality and warrants follow-up evaluation.

Chronic constipation was associated with worse cognitive function, equal to 3 years of additional aging, according to research presented at the Alzheimer’s Association International Conference.

The first half of 2023 has already seen landmark FDA decisions in the gastroenterology space, including multiple first-in-class therapies along with two costly rejections that highlight persistent gaps in the GI drug armory.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

The FDA has approved Linzess, the first therapy for pediatric functional constipation in patients aged 6 to 17 years, according to an agency release.

CHICAGO — In a Healio video exclusive, Claire Jansson-Knodell, MD, shares data that show pregnant women with celiac disease are at greater risk for placental diseases, obstetric complications and having babies small for gestational age.

CHICAGO — A large knowledge gap identified between gastroenterologists and primary care physicians in the diagnosis and management of patients with celiac disease highlights the need for further education for general practitioners.